BrachyDOSE is a healthcare startup with the slogan "We help hospitals to reduce radiotherapy service costs." Founded in 2014 in Lithuania, the company has received a €30.00K Grant investment at 25 June 2019 from The European Innovation Council and EIT Health.
BrachyDOSE offers a game-changing cancer treatment quality control tool aimed at empowering oncology doctors to provide 100% accurate and error-free radiotherapy treatment. Their solution addresses a critical issue affecting over 200 million patients worldwide and more than 2000 hospitals in Europe and the USA.
The startup's innovative approach combines hardware dose measurement tools with deep learning algorithms to provide high-accuracy data. This not only ensures precise treatment but also has the potential to reduce overall treatment costs per patient by 3-5 times. Additionally, it can save up to 50% of doctors' and medical specialists' time for procedure preparation, ultimately assisting cancer patients in returning to normal life sooner.
BrachyDOSE's mission is to provide medical professionals with empowering innovative solutions for safe and highly effective treatment. The company values quality, innovation, and partnership, and their vision is to help medical professionals combat cancer in every hospital worldwide.
No recent news or press coverage available for BrachyDOSE.